NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









MiMARK Diagnostics

MiMARK Diagnostics

Private
BarcelonaHealthcare & Life Scienceshttps://www.mimark.es/

Last Round

Seed

Nov 27, 2023

Total Funding Raised

$6.44M

Company Overview

MiMARK Diagnostics is a biotechnology company developing in-vitro diagnostic solutions for gynecological diseases, with an initial focus on a test for endometrial cancer.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Application

Keywords

endometrial cancerin vitro diagnosticIVDbiomarker discoverygynecological diagnosticsproteomicsliquid biopsybioinformaticsdiagnostic testprecision medicineclinical validationnon-invasive testingearly cancer detectionbiotech startup

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MiMARK Diagnostics Comps

Public and private peers based on sector, stage, and business model.

MiMARK Diagnostics comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

MiMARK Diagnostics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedNov 27, 2023
GrantFeb 11, 2021

Key People

Founding team and executive leadership

Eva Colás

Chief Scientific Officer Co-Founder

Founding Team

Marina Rigau

CEO And Co-founder

Founding Team

Maria de Marti Villalba

Chief Technology Officer

Executive Team

Agustí Soler Casas

Interin CFO Board Observer

Executive Team

MiMARK Diagnostics Investors

Notable investors and investment history

MiMARK Diagnostics investors
InvestorRounds
European Innovation Council FundSeed
CDTI InnvierteSeed
InvereadySeed
EIT HealthGrant
Nara CapitalSeed
Namarel VenturesSeed
Clave CapitalSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 16, 2026

    Grew 27% QoQ, from 22 to 28 employees.

  • Feb 20, 2024

    Grew 50% QoQ, from 12 to 18 employees.

MiMARK Diagnostics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

MiMARK Diagnostics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about MiMARK Diagnostics's valuation, stock price, and market status.

Firmographic Details

HeadquartersBarcelona
Employee Range30
Year Founded2021
Last FundingNov 27, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.